Abattis Bioceuticals (Abattis Bioceuticals) Total Liabilities : $6.49 Mil (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Total Liabilities?

Abattis Bioceuticals's Total Liabilities for the quarter that ended in Sep. 2019 was $6.49 Mil.

Abattis Bioceuticals's quarterly Total Liabilities increased from Mar. 2019 ($0.24 Mil) to Jun. 2019 ($6.62 Mil) but then declined from Jun. 2019 ($6.62 Mil) to Sep. 2019 ($6.49 Mil).

Abattis Bioceuticals's annual Total Liabilities declined from Sep. 2017 ($0.36 Mil) to Sep. 2018 ($0.23 Mil) but then increased from Sep. 2018 ($0.23 Mil) to Sep. 2019 ($6.49 Mil).

Abattis Bioceuticals Total Liabilities Historical Data

The historical data trend for Abattis Bioceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Total Liabilities Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Total Liabilities

Get a 7-Day Free Trial

0.86

0.81

0.36

0.23

6.49

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Liabilities	Get a 7-Day Free Trial															0.23	0.28	0.24	6.62	6.49

Abattis Bioceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Abattis Bioceuticals's Total Liabilities for the fiscal year that ended in Sep. 2019 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.71	+	(0.094	+	2.686
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6.49

Total Liabilities	=	Total Assets (A: Sep. 2019 )	-	Total Equity (A: Sep. 2019 )
	=	14.546	-	8.056
	=	6.49

Abattis Bioceuticals's Total Liabilities for the quarter that ended in Sep. 2019 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.71	+	(0.094	+	2.686
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6.49

Total Liabilities	=	Total Assets (Q: Sep. 2019 )	-	Total Equity (Q: Sep. 2019 )
	=	14.546	-	8.056
	=	6.49

Abattis Bioceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.